Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery
Thom Kok, Hans de Boer, Bart Witteman, Marcel M.C. Hovens, Matthijs van Luin, Houshang Monajemi
Topics & Concepts
ApixabanRivaroxabanMedicinePerioperativeBody mass indexInternal medicineRetrospective cohort studySurgeryAnesthesiaGastroenterologyWarfarinAtrial fibrillationAtrial Fibrillation Management and OutcomesBariatric Surgery and OutcomesCardiac, Anesthesia and Surgical Outcomes